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1. Introduction 
In the tryptophan [l] or the arginine [2] bio- 
synthetic pathway, mutants with an altered repressor 
(in the sense of Jacob and Monod, ref. [3]) have 
been isolated. With some other amino acids, histidine 
for example [4], no such mutants could ever be 
found. This failure would be compatible with some 
pathways being devoid of such a regulatory molecule, 
the regulation mechanism remaining unexplained, or 
with a repressor molecule endowed with some other 
function, essential to the metabolism of the cell. The 
first enzyme in the pathway, which is usually sensitive 
to feed-back inhibition, has long been suspected of 
playing a role in the repression mechanism. This 
hypothesis found good experimental support in the 
case of histidine [5,6] and isoleucine [7-9 J bio- 
synthesis, and in the induction of the hut operon I1 0 J . 
We will provide here evidence indicating that in 
Escherichlh coli K12 the lysine-sensitive asparto- 
kinase, first enzyme of the lysine biosynthetic path- 
way, (ZysC gene, mapping at 80 mln on the E. coli 
chromosome, ref. [ 11 J) appears to act as a positive 
regulator of the synthesis of mesodiaminopimelate 
* Abbreviations: AKI: uueonine sensitive aspartokinase 
(EC 2.7.24); AKII: me&ion&repressible aspartoums; 
AKIII: lysine-sensitive aspartokinase;.HDHI: threonine- 
sensitive homoserine d hydrogenase (EC 1 .l -1.31); 
HDHII: methionine-repressible homoscrine dehydrogenase; 
ASAdehydrogenase: aspartic semialdehyde dehydrogenase 
(EC 1.2.1.10); DAP: diaminopimelic acid; DAPkiecar- 
boxylase: mesodiaminopimelic decarboxylase (EC 
4.1.1.20). 
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decarboxylase, the last enzyme of the pathway (Zys,4 
gene, mapping at 55 min, ref. [12]). 
2. Materials and methods 
AU bacterial strains used (Escherichia cob K12) 
derive from Gif 106 (thrAIIOZ. metLMl000, arg- 
1000, iZvA, refs. [I 1 and 13 J) that has lost AKI*, 
AIUI and HDHII activities, AKIII and HDHI activities 
being conserved. 106 G2 1 (same genotype as Gif 106, 
plus @CIOO2, refs. [ 11 and 131) is a lysine resistant 
mutant of Gif 106; its AK111 activity is desensitized 
towards lysine, the feed-back inhibitor. ORAlOl is a 
partially constitutive oc mutant for AK111 synthesis 
(same genotype as Gif 106, plus Zys-1100 mutation; 
J. C. Patte, M. Cassan, E. Boy and F. Borne, in pre- 
paration). ORA (same genotype as Gif 106, plus 
ZysC1002 and Zys-1100) possesses both the oc muta- 
tion of ORAl 01 and the desensitization mutation of 
106 G21.106 Ml (same genotype as Gif 106, plus 
lysCIOO1, refs. [l 1 and 13 J) derives from Gif 106 
and has lost by mutation the AK III activity. All these 
strains are also auxotrophic for isoleucine and arginine. 
Bacteria were grown and crude extracts (in 20 mM 
potassium phosphate buffer pH 6.8) were prepared 
as previously described [13] . 
Aspartokinase and aspartic semialdehyde dehydro- 
genase activities were determined as in [13]. DAP- 
decarboxylase activity was measured by a modifica- 
tion of the manometric method proposed by Work 
[14] : in order to overcome the non-measurable role 
of induced lysinedecarboxylase in our cell-free 
extracts, purified lysinedecarboxylase was added in 
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excess to the incubation mixture: 2 moles of CO2 
were then produced for 1 mole of DAP. The incu- 
bation mixture contained 30 ~01 DL-mesodiamino- 
pimelate (Sigma), 0.4 I.tmol pyridoxal-phosphate 
(Sigma), 1.4 unit of purified L-lysine decarboxylase 
(Sigma, type IV), 80I.tmol potassium phosphate, pH 6.8, 
in a final volume of 2.5 ml. Reaction was started by 
mixing the bacterial crude extract with the reaction 
mixture and evolving COa was measured at 37°C 
during 1 hr. Blank reactions in which enzyme or DAP 
were omitted were run in parallel. Specific activity is 
expressed in nanomoles of COz/min/mg (half of the 
COs produced in these conditions). Microbiological 
measurement (by the use of a lysine auxotroph) of 
the lysine synthesized during incubation was also per- 
formed as described in [15] . In this case, no correc- 
tion was possible for the decarboxylation of lysine 
by the induced lysinedecarboxylase in the crude 
extracts. 
3. Results and discussion 
Table 1 gives the specific activity of AKIII, ASA- 
dehydrogenase and DAPdecarboxylase of strains Gif 
106,106 G21, ORAlOl and ORA grown in 
repression conditions (in the presence of 4 mM L- 
lysine; as lysine inhibits AK111 activity in strains Gif 
106 and ORA103, thus leading to a phenotypic 
requirement for threonine and methionine, these 
amino acids were also added in excess to the growth 
medium for all strains). 
It can be seen that when strain Gif 106 is grown 
in repression conditions all the measured specific 
activities are at their maximally repressed levels (the 
AKIII and DAPdecarboxylase activities are undetect- 
able in our experimental conditions). In strain 
ORAl 01, carrying only the oc mutation (‘repressed’ 
AK111 specific activity is 23 in this strain), the 
repressed levels are also observed. In strain 106 G21, 
carrying only the desensitization mutation, AKIII 
and ASAdehydrogenase are normally repressed; 
DAP-decarboxylase activity is low, but significantly 
detectable. 
In contrast with strain ORA103, carrying both oc 
and desensitization mutations, though the repressed 
level is obtained for ASAdehydrogenase and AKIII 
(partially constitutive in this strain), DAP-decarboxyl- 
Table 1 









Mutations Specific activity (nmol/min/mg) 
Growth conditions 
1 2 3 AK111 ASAdehydrogenase DAPdecarboxylase 
+ + + Minimal med. (a) 37 1080 5.8 
Repression (b) < 1.5 350 < 0.3 
+ d + Repression < 1.5 340 0.9 
oc + + Repression 23 330 < 0.3 
oc d + Repression 23 340 5.1 
+ ? (c)- Repression 0 340 < 0.3 
lysine limitation (e) 0 4800 5.5 
1: oc Mutation Zys-I 100 leading to partially constitutive synthesis of AKIII; 
2: ZysC1002 Mutation leading to desensitization (d) of AK111 activity; 
3: Mutation leading to the loss of AK111 activity. 
(a) The auxotrophic requirements of the strain were met by addition of 0.5 mM L-isoleucine and 0.5 mM 
Garginine. 
(b) Repression conditions are 4 mM L-lysine (plus 5 mM DL-threonine, 2 mM DL-methionine, 2 mM 
L-isoleucine and 0.5 mM DL-arginine, see text). 
(c) This strain having lost AKIII activity, it is presumed that the allosterlc lysine site is not modified by the 
mutation_ 
(e) Growth in the presence of 75 PM DAP (plus threonine, methionine, isoleucine and arginine as above). 
In these conditions, growth is limited by the lysine pool at a concentration of about lo9 bacteria/ml. 
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ase specific activity is much higher than the repressed 
level (approximately at the level obtained with the 
parental strain Gif 106 grown in minimal medium). 
Similar variations between the different strains were 
also observed when the microbiological test was used. 
Thus in strain ORA the simultaneous presence 
of the two separately ineffective mutations leads to 
a partially constitutive synthesis of DAPdecarboxyl- 
ase, even in the presence of an excess of lysine. The 
possibility that in this strain 4 mM L-lysine will not 
lead to the maximal repression has been ruled out: 
ASAdehydrogenase is normally repressed at this 
lysine concentration, and DAPdecarboxylase specific 
activity does not decrease when 10 mM L-lysine is 
used. 
Intracellular phenotypic variations can be predicted 
between the different strains, due to the different 
genotypes. As a matter of fact it appears that, in the 
case of Gif 106,106 G21 and ORAlOl, no (or traces 
of) aspartylphosphate is synthesized: either because 
there is no aspartokinase activity after repression 
(Gif 106,106 G21) or because the enzyme, when 
present (ORAIOI), has its activity inhibited in vivo 
by lysine, the allosteric ligand; in strain ORA103, the 
enzyme is not completely repressed and its activity 
is no longer sensitive to lysine inhibition, thus 
aspartyl phosphate is always ynthesized. The same 
reasoning can also lead to the following consideration: 
the AKIII protein, under its non-inhibited allosteric 
configuration [16], is only present in the cells of 
strain ORA103; in the others, either the enzyme is 
absent (due to repression) or it is under its inhibited 
configuration, by allosteric interaction. 
Thus two hypotheses arise: either aspartyl phos- 
pnate is the co-inducer of DAPdecarboxylase SO- 
thesis, or the non-inhibited AKIII protein itself is 
required to induce the transcription of the Zyti gene 
(the reverse possibility, that inhibited AK111 might 
repress transcription of the ZysA gene appears un- 
likely: the decrease of AKIII synthesis by repression 
would normally lead in this case to a derepression of
DAPdecarboxylase synthesis). 
The low, but detectable, DAPdecarboxylase 
activity observed with strain 106 G21 is in agreement 
with both hypotheses if one admits that the AKIII 
synthesis, though undetectable inour experimental 
conditions, is not completely repressed and that some 
molecules of enzyme are present in the cell ln the 
non-inhibited form (due to desensitization) allowing 
a little aspartyl-phosphate synthesis. 
The role of aspartyl-phosphate has been studied 
(table 1) on strain 106 Ml, a 1ysC mutant in which 
AKIII activity is lost [13 1. In this strain no asparto- 
kinase activity exists such as allows aspartyl-phosphate 
synthesis. When this strain is grown on limiting con- 
centration of lysine (as verified by the partial ASA- 
dehydrogenase d repression [ 131) a strong de- 
repression of DAPdecarboxylase isalso observed (in 
repression conditions, the repressed levels are nor- 
mally obtained for both enzymes). Since DAP- 
decarboxylase ynthesis i  observed in the absence of 
aspartylphosphate synthesis, the role of this metabolite 
as an inducer is ruled out. The derepression of DAP- 
decarboxylase in these conditions may then be ex- 
plained with our second hypothesis, if one admits that 
the AKIII protein of 106 Ml, though catalytically 
inactive, is normally synthesized in derepression con- 
ditions and may then act as an inducer. 
These experiments seem to indicate that the AKIII 
protein, first enzyme of the lysine biosynthetic path- 
way, plays a role in the regulation of the synthesis of 
another enzyme of the pathway. This observation is 
similar to the one described for phosphoribosyl- 
pyrophosphorylase in the histidine operon [S ,6] and 
threonine deaminase in the isoleucine-leucine-valine 
cluster [7,9] (however no operon exists in the lysine 
regulon). The structural configuration of the protein 
is likely to be involved in the regulatory mechanism, 
as recently observed for the in vitro induction of the 
hut operon by non-adenylated glutamine synthetase 
[ 10 1. This hypothesis is in agreement with the pre- 
viously published observation [15] that an excess of 
lysine during growth leads to repression of DAP- 
decarboxylase ynthesis; lysine however does not 
interfere directly, as suggested by this result, but by 
its action on AKIII synthesis and activity. 
Further experiments are required to confirm this 
hypothesis and to see whether other regulatory 
mechanisms are involved in parallel. Non-sense mutants 
in the ZysC gene could be isolated, proximal enough 
to the operator egion to allow the synthesis of only 
a very short polypeptide (unfortunately a precise 
mapping of these mutations would be difficult, as no 
distal genes exist for demonstrating polar effects); 
in such mutants, DAPdecarboxylase synthesis hould 
not occur. A more direct confirmation will be obtained 
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by using in vitro transcription experiments, with a 
Uys.4 phage as a source of DNA; such a phage has 
been recently described by Shimada et al. I17 1. These 
experiments are currently& progress. 
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